Literature DB >> 10940638

Biochemistry, physiology and pathophysiology of the extracellular calcium-sensing receptor.

N Chattopadhyay1.   

Abstract

Calcium (Ca(2+)) has long been recognized as a physiologically indispensable ion owing to its numerous intra- and extracellular roles. More recently, it has become apparent that extracellular calcium (Ca(2+)(o)) also serves as an extracellular first messenger following the cloning of a Ca(2+)(o)-sensing receptor (CaR) that belongs to the superfamily of G protein-coupled receptors (GPCR). The CaR probably functions as a dimer in performing its central role of "sensing" minute alterations in Ca(2+)(o) and adjusting the secretion of parathyroid hormone (PTH) so as to normalize Ca(2+)(o) through the actions of PTH on the effector elements of the mineral ion homeostatic system (e.g., kidney, bone and intestine). Several inherited human conditions are caused by inactivating or activating mutations of this receptor, and mice have been generated with targeted disruption of the CaR gene. Characteristic changes in the functions of parathyroid and kidney in patients with these conditions and in CaR-deficient mice have proven the physiological importance of the CaR in mineral ion homeostasis. An accumulating body of evidence, however, suggests that the CaR also plays numerous roles outside the realm of systemic mineral ion homeostasis. The receptor regulates processes such as cellular proliferation and differentiation, secretion, membrane polarization and apoptosis in a variety of tissues/cells. Finally, the availability of specific "calcimimetic", allosteric CaR activators - which are currently in clinical trials - will probably have therapeutic implications for diseases caused by malfunction of the CaR in tissues not only within, but also outside, the mineral ion homeostatic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940638     DOI: 10.1016/s1357-2725(00)00031-5

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  10 in total

1.  Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.

Authors:  Ping Chen; Adimoolam Narayanan; Benjamin Wu; Per Olsson Gisleskog; John P Gibbs; Andrew T Chow; Murad Melhem
Journal:  Clin Pharmacokinet       Date:  2018-01       Impact factor: 6.447

2.  A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport.

Authors:  M Hershfinkel; A Moran; N Grossman; I Sekler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 3.  Hyperparathyroidism in the elderly patient.

Authors:  Rebecca Sims; Charanjeit Ubhi; David Hosking
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Normocalcemic primary hyperparathyroidism in patients with recurrent kidney stones: pathological analysis of parathyroid glands.

Authors:  An-Hang Yang; Chih-Wei Hsu; Jui-Yu Chen; Ling-Ming Tseng; Ging-Shing Won; Chen-Hsen Lee
Journal:  Virchows Arch       Date:  2006-05-03       Impact factor: 4.064

5.  Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor.

Authors:  Anson K Abraham; Tristan S Maurer; Amit S Kalgutkar; Xiang Gao; Mei Li; David R Healy; Donna N Petersen; David A Griffith; Donald E Mager
Journal:  AAPS J       Date:  2011-03-25       Impact factor: 4.009

Review 6.  The myoendothelial junction: breaking through the matrix?

Authors:  Katherine R Heberlein; Adam C Straub; Brant E Isakson
Journal:  Microcirculation       Date:  2009-03-26       Impact factor: 2.628

7.  Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.

Authors:  P Chen; P Olsson Gisleskog; J J Perez-Ruixo; J Xiao; J Wilkins; A Narayanan; J P Gibbs; M Melhem
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-09-17

8.  Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic-pharmacodynamic analysis of cinacalcet.

Authors:  Ping Chen; Winnie Sohn; Adimoolam Narayanan; Per Olsson Gisleskog; Murad Melhem
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

9.  Activation of the Calcium Sensing Receptor Decreases Secretagogue-Induced Fluid Secretion in the Rat Small Intestine.

Authors:  Maria J Barahona; Renee M Maina; Taras Lysyy; Michele Finotti; Giorgio Caturegli; Vanessa Baratta; Francesco D'Amico; David Mulligan; John P Geibel
Journal:  Front Physiol       Date:  2019-05-03       Impact factor: 4.566

Review 10.  Family C G-Protein-Coupled Receptors in Alzheimer's Disease and Therapeutic Implications.

Authors:  Ilaria Dal Prà; Ubaldo Armato; Anna Chiarini
Journal:  Front Pharmacol       Date:  2019-10-28       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.